Desonide foam: a review

Drugs Today (Barc). 2008 Jan;44(1):55-62. doi: 10.1358/dot.2008.44.1.1143847.

Abstract

Desonide foam is a newly approved topical corticosteroid preparation of 0.05% desonide. It has been shown effective compared with vehicle placebo in the treatment of mild-to-moderate atopic dermatitis in both pediatric and adult populations. Given the favorable safety profile of all other desonide preparations and their utility as a low potency corticosteroid, desonide foam promises to be a useful addition to the armamentarium, when other desonide vehicles might be less acceptable.

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Adrenal Cortex Hormones* / administration & dosage
  • Adrenal Cortex Hormones* / adverse effects
  • Adrenal Cortex Hormones* / pharmacology
  • Adrenal Cortex Hormones* / therapeutic use
  • Adult
  • Anti-Inflammatory Agents* / administration & dosage
  • Anti-Inflammatory Agents* / adverse effects
  • Anti-Inflammatory Agents* / pharmacology
  • Anti-Inflammatory Agents* / therapeutic use
  • Child
  • Dermatitis, Atopic / drug therapy*
  • Desonide* / administration & dosage
  • Desonide* / adverse effects
  • Desonide* / pharmacology
  • Desonide* / therapeutic use
  • Humans
  • Pharmaceutical Vehicles

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Pharmaceutical Vehicles
  • Desonide